E Fund Management Co. Ltd. Raises Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

E Fund Management Co. Ltd. increased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 98.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,791 shares of the medical device company’s stock after buying an additional 1,878 shares during the quarter. E Fund Management Co. Ltd.’s holdings in Cooper Companies were worth $349,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC purchased a new position in Cooper Companies during the 3rd quarter valued at $25,000. Byrne Asset Management LLC purchased a new position in Cooper Companies during the 4th quarter valued at $33,000. Covestor Ltd increased its position in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares during the period. Brown Brothers Harriman & Co. increased its position in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. Finally, West Financial Advisors LLC purchased a new position in Cooper Companies during the 4th quarter valued at $49,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $85.00 on Friday. The stock has a market cap of $16.96 billion, a price-to-earnings ratio of 43.59, a PEG ratio of 2.25 and a beta of 1.02. The firm’s 50-day moving average is $92.38 and its 200 day moving average is $99.40. The Cooper Companies, Inc. has a 1 year low of $82.61 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on COO. Piper Sandler reissued an “overweight” rating and set a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research report on Friday. Morgan Stanley reduced their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday. Citigroup dropped their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday. Finally, StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.